Home > Healthcare > Medical Devices > Implantable Devices > Cardiac Prosthetic Devices Market

Cardiac Prosthetic Devices Market Share

Report ID: GMI1965
Published Date: Aug 2023
Report Format: PDF

Download Free Sample

Cardiac Prosthetic Devices Market Share

Some of the major players operating in the cardiac prosthetic devices market are

Abbott Laboratories
Abiomed, Inc.
AtriCure, Inc.
Biotronik
Boston Scientific Corporation
CryoLife, Inc.
Edwards Lifesciences Corporation
Labcor Laboratrios
Lepu Medical Technology Co. Ltd.
Lifetech Scientific
LivaNova
Medtronic plc.
Meril Life Sciences Pvt. Ltd.
MicroPort Scientific
Siemens Healthcare GmbH

These leading market players are implementing advanced technologies to cater to the large unmet needs of the consumers. These players focus on strategic partnerships, new product launch & commercialization for market expansion.

Authors: Mariam Faizullabhoy , Shishanka Wangnoo

Frequently Asked Questions (FAQ) :

Cardiac prosthetic devices industry value was USD 7.2 billion in 2022 and is projected to reach over USD 16.4 billion by the end of 2032.

The hospitals segment held a dominant market share worth USD 3.5 billion in 2022 and will expand through 2032 as cardiac prosthetic devices play a pivotal role in providing medical care, including cardiac interventions and procedures.

North America cardiac prosthetic devices market size was more than USD 3 billion in 2022 and is expected to witness substantial growth through 2032 owing to factors like the presence of significant players, increasing prevalence of cardiovascular diseases, technological advancements, access to healthcare, and an aging population.

Abbott Laboratories, Abiomed, Inc., AtriCure, Inc., Biotronik, Boston Scientific Corporation, CryoLife, Inc., Edwards Lifesciences Corporation, Labcor Laboratrios, Lepu Medical Technology Co. Ltd., Lifetech Scientific, LivaNova, Medtronic plc., Meril Life Sciences Pvt. Ltd., MicroPort Scientific, Siemens Healthcare GmbH among others.